Skip to content

Application of pulmonary protective ventilation in infant laparoscopic surgery

Application of pulmonary protective ventilation in infant laparoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058653
Enrollment
Unknown
Registered
2022-04-13
Start date
2022-04-13
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung injury

Interventions

Traditional ventilation group:Conventional tidal volume ventilation
Lung protective ventilation group:Low tidal volume6ml/kg
Lung protective ventilation group:Positive end expiratory pressure5 cmH2O
Lung protective ventilation group:intermittent lung recruitment

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 6 Months

Inclusion criteria

Inclusion criteria: 1. Regardless of sex, age from 1 month to 6 months; 2. ASA grade I-II; 3. Elective laparoscopic surgery; 4. After fully explaining the contents of the clinical trial, the family members of the patients voluntarily tested and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with poor pulmonary ventilation; 2. Patients known to be allergic to narcotic drugs such as ropivacaine and cisatracurium; 3. Patients with asthma, epilepsy and cardiac insufficiency before operation; 4. Patients with abnormal liver and kidney function; 5. Patients judged to be family members who lack the ability of consent; 6. Patients with potential non-injury in basic diseases before operation. Such as severe infection, sepsis, patients with reflux aspiration, etc. 7. Patients with postoperative ICU support treatment with tube; 8. Patients with postoperative ventilation difficulties in the ward and need ventilator support treatment; 9. Patients with serious adverse events, according to the doctor's judgment, the trial should be stopped; 10. Sollow up shedding cases.

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications;Intraoperative respiratory parameters;Arterial blood gas parameters;

Secondary

MeasureTime frame
Postoperative hospital stay;C-reactive protein concentration;Body temperature 24 hours after operation;Extubation time;Postoperative PACU residence time;

Countries

China

Contacts

Public ContactQi Chen

The Second Affiliated Hospital of Anhui Medical University

1228022438@qq.com+86 13866103453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026